Drug Discount Monitor: Protect 340B, Cardiologist Asks Congress at Hearing on Drug Prices

The chief clinical officer of one of Indiana’s largest safety-net hospitals implored Congress to protect the 340B drug discount program in light of “hyperinflation in pharmaceutical pricing.” “I understand that ...

The Daily Caller: A Win For Drug Companies Leaves Taxpayers Holding The Bag

While drug company executives are enjoying rapidly escalating medicine prices, hardworking Americans are watching more and more of their paychecks disappear every month at the pharmacy. There’s a largely unknown ...

Fierce Health Finance: 340B hospitals spend less than other institutions for Part B drugs

A new study by an advocacy group for safety-net hospitals say that participants in the 340B drug discount program spend less per patient under Medicare Part B for drugs than ...

Modern Healthcare: Proposed changes to 340B could drive away a third of participating hospitals

Up to a third of hospitals currently participating in the 340B drug-pricing program say they would consider opting out if proposed regulatory changes are finalized, a leading advocacy group said ...

Senate HELP Hearing “Perspectives on the 340B Drug Discount Program” Scheduled March 15

The Senate Committee on Health, Education, Labor and Pensions (HELP), which has Senate jurisdiction over the 340B program, will hold a hearing titled “Perspectives on the 340B Drug Discount Program” ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields